Reference/

treatment

Patients

Prior treatment

Efficacy response %

Survival analysis

Radiation therapy %

Chemotherapy %

Total No.

CR

PR

SD

PFS (%)

OS (%)

Median-months

6 months

Median-months

6 months

1 year

2 years

5 years

10 years

Lashford et al., 2002, Temozolomide [21]

43

All

63

0

9

14

4.8

Nicholson et al., 2007Temozolomide [22]

23

84

All

0

4

30

Warren et al., 201206-benzylguanine and temozolomide [23]

41

All

1 median chemo therapy regimen

0

2

12

16*

0**

Burzynski et al., 2014ANP(Study eligible)

41

90.2

80.5

2.4

9.8

17.1

2.5

22

4.8

46.3

12.2

4.8

4.8

4.8

Burzynski et al., 2014ANP (DIPG)

12

91.6

75.0

8.3

25

33.3

4.8

41.7

6.1

58.3

25.0

8.3

8.3

8.5

Burzynski et al., 2014ANP (AA)

8

87.5

75

0

12.5

12.5

3.7

25.0

4.7

37.5

12.5

12.5

12.5

12.5